Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (251-260 of 349) with videos related to

Pageof 35
Sort By:
Urology|March 8, 2013
Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillanceYun-Sok Ha, Amirali Salmasi, Michael Karellas, et al.
Urology|June 19, 2007
Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men?John C Mavropoulos, Alan W Partin, Christopher L Amling, et al.
The Prostate|December 1, 2011
AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomyEli Rosenbaum, Shahnaz Begum, Mariana Brait, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Gleason score 6 adenocarcinoma: should it be labeled as cancer?H Ballentine Carter, Alan W Partin, Patrick C Walsh, et al.
The Journal of Urology|August 12, 2017
Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate CancerEva Shrestha, James R White, Shu-Han Yu, et al.
European Urology|June 28, 2014
The relationship between the extent of extraprostatic extension and survival following radical prostatectomyByong Chang Jeong, Heather J Chalfin, Seung Bae Lee, et al.
BJU International|July 28, 2012
An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011John B Eifler, Zhaoyang Feng, Brian M Lin, et al.
Urology Case Reports|March 16, 2018
Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [<sup>18</sup>F]DCFPyL PET/CT: Value of the PSMA-RADS-3D DesignationEugene Shenderov, Michael A Gorin, Seohyun Kim, et al.
BJU International|September 30, 2010
Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason scoreYing Huang, Sumit Isharwal, Alexander Haese, et al.
Cancer Biomarkers : Section a of Disease Markers|September 26, 2015
Evaluation of two mitochondrial DNA biomarkers for prostate cancer detectionSamantha Maragh, Robert W Veltri, Steven P Lund, et al.
Pageof 35

Showing results (251-260 of 349) with videos related to

Sort By:
Pageof 35
Urology|March 8, 2013
Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillanceYun-Sok Ha, Amirali Salmasi, Michael Karellas, et al.
Urology|June 19, 2007
Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men?John C Mavropoulos, Alan W Partin, Christopher L Amling, et al.
The Prostate|December 1, 2011
AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomyEli Rosenbaum, Shahnaz Begum, Mariana Brait, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Gleason score 6 adenocarcinoma: should it be labeled as cancer?H Ballentine Carter, Alan W Partin, Patrick C Walsh, et al.
The Journal of Urology|August 12, 2017
Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate CancerEva Shrestha, James R White, Shu-Han Yu, et al.
European Urology|June 28, 2014
The relationship between the extent of extraprostatic extension and survival following radical prostatectomyByong Chang Jeong, Heather J Chalfin, Seung Bae Lee, et al.
BJU International|July 28, 2012
An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011John B Eifler, Zhaoyang Feng, Brian M Lin, et al.
Urology Case Reports|March 16, 2018
Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [<sup>18</sup>F]DCFPyL PET/CT: Value of the PSMA-RADS-3D DesignationEugene Shenderov, Michael A Gorin, Seohyun Kim, et al.
BJU International|September 30, 2010
Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason scoreYing Huang, Sumit Isharwal, Alexander Haese, et al.
Cancer Biomarkers : Section a of Disease Markers|September 26, 2015
Evaluation of two mitochondrial DNA biomarkers for prostate cancer detectionSamantha Maragh, Robert W Veltri, Steven P Lund, et al.
Pageof 35